TABLE 2.
Characterization of fusion peptide mutants
| Peptidea | Cell surface expression | Processing | Oligomer (trimer) | Receptor binding | SU* production
|
Infectivityb | Env viral incorporation | Fusion | |
|---|---|---|---|---|---|---|---|---|---|
| −Tva | +Tva | ||||||||
| wt | + | + | + | + | − | + | 3.3 × 105 | + | + |
| Mutants | + | + | |||||||
| Position 1 | |||||||||
| Glu | + | + | + | + | − | + | 2.3 × 104 | + | − |
| Lys | + | + | + | + | − | + | 1.8 × 103 | + | − |
| Position 2 | |||||||||
| Glu | + | + | + | + | − | + | 2.5 × 103 | + | − |
| Lys | + | + | + | + | − | + | 9.0 × 102 | + | − |
| Position 3 | |||||||||
| Glu | + | +/− | + | + | + | + | 2.2 × 102 | + | − |
| Lys | + | +/− | + | + | + | + | 7.5 × 100 | + | − |
Positions 1, 2, and 3 are underlined, in that order, in the sequence I F A S I L A P G V A A A Q A L R E I E R L.
Expressed as infectious units per milliliter of viral stock.